Aurigene Discovery Technologies Limited

This early-stage study tested an oral drug called AUR104 in 9 adults with relapsed or refractory lymphoid cancers (like certain lymphomas or leukemias). The main goal was to check the drug's safety and find the right dose. The study was terminated early, so results are limited.

This study tested three different doses of an experimental drug called AUR 109 in 29 adults with advanced colorectal, ovarian, or kidney cancer who had already tried at least two other treatments. The goal was to see if the drug could shrink tumors and to check its safety. Howeve…

This early-stage study tested a new drug called AUR103 Calcium in 27 adults with advanced cancers that had stopped responding to standard treatments. The goal was to find a safe dose and see how the drug worked in the body. The trial was terminated early, so no final results are …

This early-stage study tested a new drug called AUR103 combined with standard treatments (trastuzumab and chemotherapy) for people with advanced HER2-positive stomach or gastroesophageal junction cancer. The goal was to see if the combination was safe and effective. However, the …